At a glance
ClinicalIndex Comparison RecordN/ACompleted· 153 enrolled
Drug / intervention
Objective measures with CSEPdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Trans-impedance Matrix
In Brief
An observational study evaluating Objective measures with CSEP for Hearing Loss. Completed, enrolled 153 participants across 6 sites in 3 countries.
Detailed Summary
The aim of this descriptive study is to collect and describe the characteristics of objective measures to explore the specificity of algorithms.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesAustralia, Germany, Spain
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartOct 2017
Primary CompletionMay 2019
TodayJul 2026
First PostedSep 27, 2017
Enrollment StartOct 3, 2017
Primary CompletionMay 29, 2019
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 8.8 years ago
Interventions
Objective measures with CSEPdevice
Objective measures to be conducted with Custom SoundTM EP 5 software and the CP900 series sound processor in CI532 and CI512 Cochlear Implant recipients